Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer

Abroad (travel likely)RecruitingPHASE1

Conditions

Metastatic Castration-resistant Prostate Cancer · Advanced Prostate Adenocarcinoma · PSCA-positive Prostate Cancer · PSMA-Positive Progressive Metastatic Castration-Resistant Prostate Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Peking University Shenzhen Hospital, Shenzhen, Guangdong, China
Contact: Study coordinator (Zhen J Peng, Phd) · Zhen-Peng@beijing-biotech.com · +86 13076790039

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

ARCTIC: Liquid Biomarkers in the Prospective Androgen Receptor Signaling Inhibitors (ARSI) Resistance Clinical Trials

Prostate Cancer · Prostate Adenocarcinoma · Prostate Cancer Metastatic

Abroad (travel likely)Recruiting

New York, United States · Durham, United States

A Phase I Trial of A-CAR032 in Participants With mCRPC

Prostate Cancer · Metastatic Castration-Resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE1

Beijing, China · Beijing, China

Study of JANX014 in Subjects With Metastatic Castration-Resistant Prostate Cancer

Prostate Cancer · Metastatic Castration-resistant Prostate Cancer · Castration-resistant Prostate Cancer

Abroad (travel likely)RecruitingPHASE1

Nashville, United States

HER2 FPBMC in Patients With Metastatic Breast and Prostate Cancer (AM006)

Breast Cancer · Prostate Cancer

Abroad (travel likely)RecruitingPHASE1, PHASE2

Charlottesville, United States